| Name | Title | Contact Details |
|---|
Phathom Pharmaceuticals, launched in 2019 by Frazier Healthcare Partners and Takeda Pharmaceuticals, is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal (GI) diseases and disorders. The company is advancing the investigational agent vonoprazan, a novel potassium-competitive acid blocker (P-CAB). Vonoprazan has the potential to address multiple unmet needs among patients with gastroesophageal reflux disease (GERD) and other acid-related disorders.
Olson Pharmacy Services is a Oregon City, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Greater Nashua Mental Health believes in empowering people to lead full and satisfying lives through effective treatment and support.
Groupe Essaim Inc. is a Boucherville, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cabrellis is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.